![Michael Schultz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Michael Schultz served as a Member-Supervisory Board at MOLOGEN AG from 2018 to 2020.
He also worked as the President & Chief Scientific Officer at Chembridge Research Laboratories, Inc.
Eerdere bekende functies van Michael Schultz
| Bedrijven | Functie | Einde |
|---|---|---|
| MOLOGEN AG | Directeur/Bestuurslid | 30-07-2020 |
Chembridge Research Laboratories, Inc.
 Chembridge Research Laboratories, Inc. Medical DistributorsDistribution Services Discovers molecule drugs | President | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
6
Eerstegraads connecties
2
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
MOLOGEN AG
 MOLOGEN AG Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immunotherapies for the treatment of infectious diseases | Health Technology |
Chembridge Research Laboratories, Inc.
Chembridge Research Laboratories, Inc. Medical DistributorsDistribution Services Discovers molecule drugs | Distribution Services |
